Health and Healthcare
5865 Articles
Athersys has announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy…
Ardelyx recently filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap…
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Jaguar Animal Health has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny.…
Dynavax Technologies led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down…
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…
The U.S. Securities and Exchange Commission (SEC) has received a filing from Tabula Rasa HealthCare regarding its initial public offering…
Exelixis Inc. (NASDAQ: EXEL) was up slightly in Tuesday’s trading session following positive results from a late stage trial. The…
Janney Capital has weighed in on biotech company Acceleron Pharma and what its outlook stands to be for the future.
MannKind Corp. (NASDAQ: MNKD) is one of the most traded biotech companies on the market, and one of the most…
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
Bavarian Nordic has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Our top personal finance-related articles today. Your wallet will thank you later.